OTR Therapeutics
PrivateLast Round
Series A
Jun 1, 2025
Total Funding Raised
$100M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
OTR Therapeutics is a biotechnology company that discovers and acquires preclinical assets to develop transformative therapies for oncology, immunology, and metabolic disorders.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OTR Therapeutics Comparables
Compare OTR Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MindRank | 79% | |
| Nimbus Therapeutics | 73% | |
| Protuoso Biosciences | 72% |
OTR Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 1, 2025 |
OTR Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sirona Capital | Series A |
| True Light Capital | Series A |
| Pfizer Ventures | Series A |
| Lilly Asia Ventures | Series A |
| Pfizer Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 3, 2026
Grew 50% QoQ from 8 to 12 employees.
- Jul 28, 2026
Grew 38% QoQ, from 8 to 11 employees.
Recent news
Latest coverage and updates
- is_developingJul 9, 2026
Otr Tx is developing novel oncology assets originating from China on Jul 9th '26.
- is_developingJul 8, 2026
Otr Tx is developing Novel Oncology Therapies.
- partners_withJul 7, 2026
Otr Tx partnered with LG Chem Ltd on Jul 8th '26.
OTR Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about OTR Therapeutics's valuation, stock price, and market status.
Is OTR Therapeutics a public or private company?
OTR Therapeutics is a private company.
What is the current stock price of OTR Therapeutics?
OTR Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is OTR Therapeutics worth (valuation)?
Valuation information for OTR Therapeutics is not publicly available.
Can I buy OTR Therapeutics stock?
OTR Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was OTR Therapeutics's last funding round?
OTR Therapeutics's most recent funding round was Series A on June 1, 2025.
Who are the main investors in OTR Therapeutics?
Key investors in OTR Therapeutics include Sirona Capital, True Light Capital, Pfizer Ventures.
Will OTR Therapeutics IPO soon?
No public IPO plans have been announced for OTR Therapeutics.
How can I track OTR Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor OTR Therapeutics's secondary market activity and sign up for updates.